Tevogen Bio Return On Asset vs. Market Capitalization
| TVGN Stock | 1.01 0.01 1.00% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 0.0919 | 0.0968 |
|
|
For Tevogen Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tevogen Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tevogen Bio Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tevogen Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tevogen Bio Holdings over time as well as its relative position and ranking within its peers.
Tevogen |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.35 | Return On Assets (5.93) |
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tevogen Bio Holdings Market Capitalization vs. Return On Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Tevogen Bio's current stock value. Our valuation model uses many indicators to compare Tevogen Bio value to that of its competitors to determine the firm's financial worth. Tevogen Bio Holdings is rated fifth in return on asset category among its peers. It also is rated fifth in market capitalization category among its peers . At this time, Tevogen Bio's Market Cap is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tevogen Bio's earnings, one of the primary drivers of an investment's value.Tevogen Market Capitalization vs. Return On Asset
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Tevogen Bio |
| = | -5.93 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Tevogen Bio |
| = | 187.3 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Tevogen Market Capitalization vs Competition
Tevogen Bio Holdings is rated fifth in market capitalization category among its peers. Market capitalization of Health Care industry is at this time estimated at about 50.51 Billion. Tevogen Bio adds roughly 187.3 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Tevogen Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Tevogen Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tevogen Bio will eventually generate negative long term returns. The profitability progress is the general direction of Tevogen Bio's change in net profit over the period of time. It can combine multiple indicators of Tevogen Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -256 K | -268.8 K | |
| Operating Income | -8.8 K | -9.3 K | |
| Net Loss | -67.3 K | -70.7 K | |
| Income Before Tax | -67.3 K | -70.7 K | |
| Total Other Income Expense Net | -58.5 K | -61.4 K | |
| Net Loss | -67.3 K | -70.7 K | |
| Income Tax Expense | 255.9 K | 268.7 K | |
| Income Quality | 20.44 | 21.47 |
Tevogen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Tevogen Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tevogen Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tevogen Bio's important profitability drivers and their relationship over time.
Use Tevogen Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tevogen Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tevogen Bio will appreciate offsetting losses from the drop in the long position's value.Tevogen Bio Pair Trading
Tevogen Bio Holdings Pair Trading Analysis
The ability to find closely correlated positions to Tevogen Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tevogen Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tevogen Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tevogen Bio Holdings to buy it.
The correlation of Tevogen Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tevogen Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tevogen Bio Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tevogen Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Tevogen Bio position
In addition to having Tevogen Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sport Products Thematic Idea Now
Sport Products
Companies manufacturing sporting goods and accessories. The Sport Products theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sport Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
To fully project Tevogen Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Tevogen Bio Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Tevogen Bio's income statement, its balance sheet, and the statement of cash flows.